<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00149201</url>
  </required_header>
  <id_info>
    <org_study_id>JCOG0106-MF</org_study_id>
    <secondary_id>C000000123</secondary_id>
    <nct_id>NCT00149201</nct_id>
  </id_info>
  <brief_title>A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis</brief_title>
  <official_title>Randomized Phase III Study of 5-FU Continuous Infusion (5FUci) Versus MTX+5-FU Sequential Therapy (MF) in Gastric Cancer With Peritoneal Metastasis (JCOG0106-MF, MF/5FU)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Japan Clinical Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Labour and Welfare, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Japan Clinical Oncology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To develop effective chemotherapy regimen against gastric cancer with peritoneal metastasis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peritoneal metastasis is common in advanced gastric cancer and is considered an incurable
      disease state. Peritoneal metastasis may cause serious complications, such as intestinal
      obstruction, massive ascites, and hydronephrosis associated with the clinical presentation of
      abdominal pain and fullness, vomiting, constipation, malnutrition and renal dysfunction.5-FU
      continuous infusion remains the mainstay for chemotherapy against gastric cancer. On the
      other, sequential MTX+5-FU was reported to be effective in advanced gastric cancer with
      peritoneal metastasis in some phase II studies. Therefore, the randomized phase III study of
      5-FU versus sequential MTX+5-FU in gastric cancer with peritoneal metastasis was conducted.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2002</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>overall survival</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>oral intake</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>toxicity</measure>
  </secondary_outcome>
  <enrollment>160</enrollment>
  <condition>Gastric Cancer</condition>
  <condition>Neoplasm Metastasis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5-FU continuous infusion</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MTX + 5-FU sequential therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. histologic confirmation of gastric adenocarcinoma

          2. inoperable metastatic disease or recurrent metastatic disease after surgery

          3. disease with peritoneal metastasis

          4. 20 years or more but less than 75 years

          5. performance status 2 or less on the Eastern Cooperative Oncology Group scale

          6. no prior treatment for gastric carcinoma except for surgery and adjuvant chemotherapy

          7. no prior chemotherapy or radiotherapy for other disease except for gastric cancer

          8. adequate bone marrow function, adequate liver function, and adequate renal function

          9. no prior transfusion for anemia

         10. provision of written informed consent

        Exclusion Criteria:

          1. Massive pleural effusion

          2. brain metastasis with symptoms

          3. severe diarrhea

          4. other severe medical conditions (infection, diabetes, hypertension, acute myocardial
             infarction, unstable angina, liver cirrhosis, intestinal pneumonia, pulmonary
             fibrosis)

          5. other active malignancies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kuniaki Shirao, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Gatrointestinal Oncology Division, National Cancer Center Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aichi Cancer Center Hospital</name>
      <address>
        <city>1-1,Kanokoden,Chikusa-ku,Nagoya</city>
        <state>Aichi</state>
        <zip>464-8681</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aichi Cancer Center,Aichi Hospital</name>
      <address>
        <city>18,Kuriyado,Kake-machi,Okazaki</city>
        <state>Aichi</state>
        <zip>444-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nagoya Medical Center</name>
      <address>
        <city>4-1-1,Sannomaru,Naka-ku,Nagoya</city>
        <state>Aichi</state>
        <zip>460-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aomori Prefectural Central Hospital</name>
      <address>
        <city>2-1-1,Higashitsukurimiti,Aomori</city>
        <state>Aomori</state>
        <zip>030-0911</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital East</name>
      <address>
        <city>6-5-1,Kashiwanoha,Kashiwa</city>
        <state>Chiba</state>
        <zip>277-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiba Cancer Center Hospital</name>
      <address>
        <city>666-2,Nitona-cho,Chuo-ku,Chiba</city>
        <state>Chiba</state>
        <zip>260-8717</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asahi General Hospital</name>
      <address>
        <city>I-1326,Asahi</city>
        <state>Chiba</state>
        <zip>289-2511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Shikoku Cancer Center</name>
      <address>
        <city>13,Horinouchi,Matsuyama</city>
        <state>Ehime</state>
        <zip>790-0007</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyushu University Hospital</name>
      <address>
        <city>3-1-1,Maidashi,Higashi-ku</city>
        <state>Fukuoka</state>
        <zip>812-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Kyushu Cancer Center</name>
      <address>
        <city>3-1-1,Notame,Minami-ku,Fukuoka</city>
        <state>Fukuoka</state>
        <zip>811-1395</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federation of national public service personnel mutual aid associations Tonan Hospital</name>
      <address>
        <city>kita 1 nishi 6,Chuo-ku,Sapporo</city>
        <state>Hokkaido</state>
        <zip>060-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hokkaido University Hospital</name>
      <address>
        <city>North-14 West-5 Kita-ku,Sapporo</city>
        <state>Hokkaido</state>
        <zip>060-8648</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hyogo Medical Center for Adults</name>
      <address>
        <city>13-70,Kitaouji-cho,Akashi</city>
        <state>Hyogo</state>
        <zip>673-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kobe University Graduate School of Medicine</name>
      <address>
        <city>7-5-2,Kusunoki-cho,Chuo-ku,Kobe</city>
        <state>Hyogo</state>
        <zip>650-0017</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ibaraki Kenritsu Chuo Hospital &amp; Cancer Center</name>
      <address>
        <city>6528,Koibuchi,Tomobemachi,Nishi-ibarakigun</city>
        <state>Ibaraki</state>
        <zip>309-1793</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iwate Prefectural Central Hospital</name>
      <address>
        <city>1-4-1,Ueda,Morioka</city>
        <state>Iwate</state>
        <zip>020-0066</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kanagawa Cancer Center</name>
      <address>
        <city>1-1-2,Nakao,Asahi-ku,Yokohama</city>
        <state>Kanagawa</state>
        <zip>241-0815</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kitasato University East Hospital</name>
      <address>
        <city>2-1-1,Asamizodai,Sagamihara</city>
        <state>Kanagawa</state>
        <zip>228-8520</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yokohama City University Medical Center</name>
      <address>
        <city>4-57,Urafunecho,Minami-ku,Yokohama</city>
        <state>Kanagawa</state>
        <zip>232-0024</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yokohama Mucipical Citizen's Hospital</name>
      <address>
        <city>56,Okazawa-cho,Hodogaya-ku,Yokohama</city>
        <state>Kanagawa</state>
        <zip>240-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kochi Health Science Center</name>
      <address>
        <city>2125-1,Ike,Kochi</city>
        <state>Kochi</state>
        <zip>781-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kumamoto Regional Medical Center Hospital</name>
      <address>
        <city>5-16-10,Honjo,Kumamoto</city>
        <state>Kumamoto</state>
        <zip>860-0811</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyoto University Hospital</name>
      <address>
        <city>54,Syogoinkawara,Sakyo-ku,Kyoto</city>
        <state>Kyoto</state>
        <zip>606-8507</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tohoku University Hospital</name>
      <address>
        <city>1-1,Seiryo-machi,Aoba-ku,Sendai</city>
        <state>Miyagi</state>
        <zip>980-0874</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saku Central Hospital</name>
      <address>
        <city>197,Usuda,Saku</city>
        <state>Nagano</state>
        <zip>384-0301</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka Medical College</name>
      <address>
        <city>2-7,Daigakucho,Takatsuki</city>
        <state>Osaka</state>
        <zip>569-0801</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saitama Medical School Hospital</name>
      <address>
        <city>38,Morohongo,Moroyama-machi,Iruma-gun</city>
        <state>Saitama</state>
        <zip>350-0495</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saitama Cancer Center</name>
      <address>
        <city>818,Komuro,Ina,Kita-adachi</city>
        <state>Saitama</state>
        <zip>362-0806</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sizuoka Cancer Center</name>
      <address>
        <city>1007,Shimonagakubo,Nagaizumi-cho,Sunto-gun</city>
        <state>Shizuoka</state>
        <zip>411-8777</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tochigi Cancer Center</name>
      <address>
        <city>4-9-13,Yohnan,Utsunomiya</city>
        <state>Tochigi</state>
        <zip>320-0834</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Showa University School of Medicine</name>
      <address>
        <city>1-5-8,Hatanodai,Shinagawa-ku</city>
        <state>Tokyo</state>
        <zip>142-8666</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Institute Hospital</name>
      <address>
        <city>3-10-6,Ariake,Koto-ku</city>
        <state>Tokyo</state>
        <zip>135-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital</name>
      <address>
        <city>5-1-1 Tsukiji, Chuo-ku</city>
        <state>Tokyo</state>
        <zip>104-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yamagata Prefectural Central Hospital</name>
      <address>
        <city>1800,Aoyagi,Yamagata</city>
        <state>Yamagata</state>
        <zip>990-2292</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <link>
    <url>http://www.jcog.jp/</url>
  </link>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2005</study_first_submitted>
  <study_first_submitted_qc>September 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <last_update_submitted>February 2, 2009</last_update_submitted>
  <last_update_submitted_qc>February 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Japan Clinical Oncology Group</name_title>
    <organization>Japan Clinical Oncology Group</organization>
  </responsible_party>
  <keyword>gastric cancer</keyword>
  <keyword>peritoneal metastasis</keyword>
  <keyword>randomized trial</keyword>
  <keyword>5-FU</keyword>
  <keyword>MTX</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorouracil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

